WallStreetZenWallStreetZen

NYSE: EBS
Emergent Biosolutions Inc Stock Ownership - Who owns Emergent Biosolutions?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Emergent Biosolutions Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Simon C. LowrySVP RD CMO2025-12-143,543$11.41
$40.43kSell
Ronald RichardDirector2025-12-0525,748$5.02
$129.25kBuy
Ronald RichardDirector2025-12-057,100$12.11
$85.99kSell
Ronald RichardDirector2025-12-0514,884$11.90
$177.09kSell
Ronald RichardDirector2025-12-0510,864$11.90
$129.26kSell
William HartzelSVP Bioservices2025-11-11610$10.88
$6.64kSell
Donald W. DegolyerDirector2025-11-1017,801$10.54
$187.62kSell
Sujata Tyagi DayalDirector2025-11-078,552$10.00
$85.52kSell
Richard S. LindahlEVP Chief Financial Officer2025-10-154,995$9.60
$47.95kSell
Coleen GlessnerEVP Quality Ethics and CPL2025-10-0730,608$10.00
$306.08kSell

1 of 3

EBS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EBS insiders and whales buy or sell their stock.

EBS Shareholders

What type of owners hold Emergent Biosolutions Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fuad Elhibri49.00%25,733,310$325.01MInsider
Intervac LLC8.27%4,344,250$54.87MInsider
Blackrock Inc8.12%4,263,123$53.84MInstitution
Oak Hill Advisors LP6.88%3,613,338$45.64MInstitution
Vanguard Group Inc6.74%3,540,670$44.72MInstitution
State Street Corp4.66%2,445,759$30.89MInstitution
American Century Companies Inc4.54%2,382,378$30.09MInstitution
Biopharm LLC4.31%2,265,043$28.61MInsider
Dimensional Fund Advisors LP4.08%2,140,340$27.03MInstitution
Robert Calvin Myers3.68%1,934,849$24.44MInsider

1 of 3

EBS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EBS45.50%54.50%Net SellingNet Selling
AQST54.16%6.24%Net SellingNet Selling
ORGO6.93%93.07%Net SellingNet Selling
IRWD69.65%30.35%Net SellingNet Selling
BIOA59.29%24.78%Net BuyingNet Buying
View Top Pharmaceutical Stocks

Emergent Biosolutions Stock Ownership FAQ

Who owns Emergent Biosolutions?

Emergent Biosolutions (NYSE: EBS) is owned by 79.39% institutional shareholders, 95.08% Emergent Biosolutions insiders, and 0.00% retail investors. Fuad Elhibri is the largest individual Emergent Biosolutions shareholder, owning 25.73M shares representing 49.00% of the company. Fuad Elhibri's Emergent Biosolutions shares are currently valued at $325.01M.

If you're new to stock investing, here's how to buy Emergent Biosolutions stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.